1. Home
  2. TARS vs BOH Comparison

TARS vs BOH Comparison

Compare TARS & BOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$65.71

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Bank of Hawaii Corporation

BOH

Bank of Hawaii Corporation

HOLD

Current Price

$80.26

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TARS
BOH
Founded
2016
1897
Country
United States
United States
Employees
N/A
1877
Industry
Medicinal Chemicals and Botanical Products
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TARS
BOH
Price
$65.71
$80.26
Analyst Decision
Buy
Hold
Analyst Count
6
5
Target Price
$89.00
$82.40
AVG Volume (30 Days)
414.5K
293.4K
Earning Date
05-05-2026
04-20-2026
Dividend Yield
N/A
3.50%
EPS Growth
48.21
N/A
EPS
N/A
N/A
Revenue
$451,360,000.00
N/A
Revenue This Year
$56.56
$15.66
Revenue Next Year
$29.94
$7.82
P/E Ratio
N/A
$17.08
Revenue Growth
146.71
N/A
52 Week Low
$38.51
$59.36
52 Week High
$85.25
$81.29

Technical Indicators

Market Signals
Indicator
TARS
BOH
Relative Strength Index (RSI) 39.66 65.42
Support Level $65.62 $69.76
Resistance Level $67.70 N/A
Average True Range (ATR) 3.04 1.91
MACD -0.37 0.44
Stochastic Oscillator 12.62 71.23

Price Performance

Historical Comparison
TARS
BOH

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

About BOH Bank of Hawaii Corporation

Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.

Share on Social Networks: